Candidaemia in a tertiary care academic hospital in Italy. The impact of C. parapsilosis complex on the species distribution and antifungal susceptibility
Purpose. To analyse the species distribution and the susceptibility profiles to the major antifungal agents of Candida isolated from bloodstream infections (BSIs) in both intensive care units (ICUs) and non-ICU wards in a tertiary care hospital in Italy from 2010 until 2015.
Methodology. Episodes of Candida BSI were recorded in a retrospective observational cohort study. Yeasts were isolated from both blood and intravascuIar devices (IVDs) and their susceptibility to antifungal drugs was tested using the microdilution method.
Results. 514 Candida BSIs were evidenced and 19 % of these episodes were associated with the presence of an IVD. The trend of the general incidence increased significantly throughout the study period, ranging from 1.42 to 3.63 (mean 2.52) episodes/1000 admissions. The incidence of Candida BSIs and IVD-associated candidaemia was significantly higher in ICUs relative to the other wards. The most frequently isolated species were C. albicans and C. parapsilosis complex, with the latter presenting a significant increased trend of isolation. C. parapsilosis complex was most frequently involved in IVD-related candidaemia, coinfections and late recurrent infections. Furthermore, the MIC50s of C. parapsilosis complex were significantly enhanced for echinocandins compared to the MIC50s for the same drugs and the other yeasts, while the MIC50s of C. albicans for amphotericin B showed a significant increase during the study period, ranging from 0.1 to 0.5 µg ml−1.
Conclusions. A progressively enhanced incidence of Candida BSIs, a relatively high impact of C. parapsilosis complex and changes in the susceptibility profiles of the isolated yeasts were evidenced during the observation period.
PfallerMA, DiekemaDJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev2007; 20:133–163 [View Article][PubMed]
WisplinghoffH, BischoffT, TallentSM, SeifertH, WenzelRP et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis2004; 39:309–317 [View Article][PubMed]
TortoranoAM, KibblerC, PemanJ, BernhardtH, KlingsporL et al. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents2006; 27:359–366 [View Article][PubMed]
BassettiM, MerelliM, RighiE, Diaz-MartinA, RoselloEM et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol2013; 51:4167–4172 [View Article][PubMed]
ChakrabartiA, SoodP, RudramurthySM, ChenS, KaurH et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med2015; 41:285–295 [View Article][PubMed]
BarchiesiF, OrsettiE, OsimaniP, CatassiC, SantelliF et al. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex. BMC Infect Dis2016; 16:387 [View Article][PubMed]
FeraMT, La CameraE, de SarroA. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther2009; 7:981–998 [View Article][PubMed]
PfallerMA, MoetGJ, MesserSA, JonesRN, CastanheiraM. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009. Antimicrob Agents Chemother2011; 55:561–566 [View Article][PubMed]
AsmundsdóttirLR, ErlendsdóttirH, GísladóttirAL, GottfredssonM. Molecular epidemiology of late recurrent candidaemia—a population-based study in Iceland. Clin Microbiol Infect2012; 18:195–201 [View Article][PubMed]
PintoA, HallidayC, ZahraM, van HalS, OlmaT et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One2011; 6:e25712 [View Article][PubMed]
PfallerMA, DiekemaDJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol2012; 50:2846–2856 [View Article][PubMed]
AlmiranteB, RodríguezD, ParkBJ, Cuenca-EstrellaM, PlanesAM et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol2005; 43:1829–1835 [View Article][PubMed]
TortoranoAM, PrigitanoA, LazzariniC, PasseraM, DeianaML et al. A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection2013; 41:655–662 [View Article][PubMed]
BassettiM, MerelliM, AnsaldiF, de FlorentiisD, SartorA et al. Clinical and therapeutic aspects of candidemia: a five year single centre study. PLoS One2015; 10:e0127534 [View Article][PubMed]
ColomboAL, NucciM, SalomãoR, BranchiniML, RichtmannR et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis1999; 34:281–286 [View Article][PubMed]
TedeschiS, TumiettoF, GiannellaM, BartolettiM, CristiniF et al. Epidemiology and outcome of candidemia in internal medicine wards: a regional study in Italy. Eur J Intern Med2016; 34:39–44 [View Article][PubMed]
Eliakim-RazN, BabaoffR, YahavD, YanaiS, ShakedH et al. Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards-a retrospective study. Int J Infect Dis2016; 52:49–54 [View Article][PubMed]
Bruder-NascimentoA, CamargoCH, SugizakiMF, SadatsuneT, MontelliAC et al. Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital. BMC Res Notes2010; 3:1 [View Article][PubMed]
DelfinoD, ScordinoF, PerniceI, Lo PassoC, GalboR et al. Potential association of specific Candida parapsilosis genotypes, bloodstream infections and colonization of health workers' hands. Clin Microbiol Infect2014; 20:O946–O951 [View Article][PubMed]
BranchiniML, PfallerMA, Rhine-ChalbergJ, FrempongT, IsenbergHD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol1994; 32:452–456[PubMed]
ShinJH, KeeSJ, ShinMG, KimSH, ShinDH et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol2002; 40:1244–1248 [View Article][PubMed]
BrunettiG, ViscontiV, GhezziMC, GiordanoA, RaponiG. The correlation between biofilm production and catheter related blood stream infections sustained by Candida. A case control study. Adv Exp Med Biol2017 in press
LevinAS, CostaSF, MussiNS, BassoM, SintoSI et al.Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis1998; 30:243–249 [View Article][PubMed]
PosteraroB, SpanuT, FioriB, de MaioF, de CarolisE et al. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Antimicrob Agents Chemother2015; 59:3944–3955 [View Article][PubMed]
PfallerMA, CastanheiraM, LockhartSR, AhlquistAM, MesserSA et al. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol2012; 50:1199–1203 [View Article][PubMed]
Candidaemia in a tertiary care academic hospital in Italy. The impact of C. parapsilosis complex on the species distribution and antifungal susceptibility